Variable | Baseline SUVmax | P value | Mid-therapy SUVmax | P value | Post-therapy SUVmax | P value | |||
---|---|---|---|---|---|---|---|---|---|
n | Mean ± SD | n | Mean ± SD | n | Mean ± SD | ||||
Age | 0.073 | 0.489 | 0.695 | ||||||
<60 years | 20 | 18.5 ± 8.5 | 13 | 4.1 ± 4.9 | 14 | 3.2 ± 3.9 | |||
≥60 years | 3 | 7.1 ± 2.6 | 2 | 6.3 ± 7.4 | 3 | 2.7 ± 4.6 | |||
Sex | 0.357 | 0.595 | 0.411 | ||||||
Male | 17 | 17.5 ± 8.5 | 11 | 4.0 ± 3.6 | 13 | 3.0 ± 2.6 | |||
Female | 6 | 15.5 ± 10.3 | 4 | 5.3 ± 8.4 | 4 | 3.6 ± 7.3 | |||
B symptoms | 1.000 | 0.953 | 1.000 | ||||||
Yes | 8 | 17.7 ± 9.1 | 7 | 3.3 ± 3.0 | 8 | 2.7 ± 2.5 | |||
No | 15 | 16.6 ± 9.0 | 8 | 5.3 ± 6.3 | 9 | 3.5 ± 5.0 | |||
Bulky diseasea | 0.069 | 0.293 | 0.164 | ||||||
Yes | 4 | 24.1 ± 5.6 | 3 | 1.8 ± 3.1 | 2 | 4.7 ± 0.6 | |||
No | 19 | 15.5 ± 8.8 | 12 | 5.0 ± 5.2 | 15 | 2.9 ± 4.1 | |||
ECOG scores | 0.014 | 0.631 | 0.363 | ||||||
<2 | 14 | 13.4 ± 7.6 | 9 | 5.2 ± 5.8 | 10 | 3.0 ± 4.8 | |||
≥2 | 9 | 22.6 ± 8.0 | 6 | 3.1 ± 3.4 | 7 | 3.3 ± 2.4 | |||
Ann arbor stage | 0.068 | 0.674 | 0.111 | ||||||
I–IIE | 10 | 14.0 ± 10.5 | 6 | 4.6 ± 4.3 | 9 | 1.8 ± 2.8 | |||
III–IVE | 13 | 19.4 ± 6.8 | 9 | 4.2 ± 5.6 | 8 | 4.7 ± 4.6 | |||
LDH | 0.156 | 0.262 | 0.618 | ||||||
≤245 | 12 | 14.9 ± 11.3 | 7 | 6.2 ± 6.3 | 8 | 3.5 ± 5.3 | |||
>245 | 11 | 19.3 ± 4.5 | 8 | 2.7 ± 3.0 | 9 | 3.0 ± 2.4 | |||
IPI scores | 0.114 | 0.368 | 0.176 | ||||||
≤2 | 14 | 15.0 ± 9.9 | 9 | 5.5 ± 5.8 | 11 | 2.8 ± 4.6 | |||
>2 | 9 | 20.2 ± 6.1 | 6 | 2.7 ± 3.1 | 6 | 3.8 ± 2.2 |